Lawsuit Help Desk

Nexium, Prilosec and Acid Reflux Lawsuits and Settlements

Have you taken Nexium, Prilosec, or any Acid Reflux Drug and later been diagnosed with Acute Interstitial Nephritis, Acute Kidney Injury, Chronic Interstitial Nephritis, Chronic Kidney Disease, Stage 4 or 5, or End Stage Renal Disease in 2020 or later? Are you under the age of 76 years old?

If yes, you are most likely to participate in an acid reflux drug lawsuit and settlement. 

Will your leading mass torts
firms take my case?

Contact us to find out (We’ll get back to you the same day)

"*" indicates required fields

I represent, understand and agree that: 1) I am 18 years of age or older; 2) I have read and agree to’s Terms of Service, Privacy Policy, that the representations here are Paid Attorney Advertising, and additional legal disclaimers herein (if any); 3) submitting this form does not create an attorney-client relationship; 4) I am not already represented by an attorney for this matter; and 5) I consent to be contacted under the Terms and Conditions of Contact in order to discuss my legal options, so that I may obtain legal representation.

Why Are Nexium, Prilosec and Other Acid Reflux Lawsuits Being Filed?

Nexium, Prilosec and other Acid Reflux drugs are a class of medications called proton pump inhibitors (PPIs). These  meds are typically used to treat gastroesophageal reflux disease (GERD), heartburn, ulcers and other more major gastrointestinal problems by reducing the acid in a person’s stomach. However, there have been claims that long-term use of these drugs can lead to increased risk of strokes, bone fractures, acute kidney injury, renal failure, and heart damage.

Current update

Currently, U.S. District Judge Clair C. Cecchi is overseeing the litigation involving over 13,000 claims against the manufacturers of Nexium, Prevacid, Prilosec, and other proton pump inhibitor (PPI) products. Consequently, she has instructed the parties involved to attend a series of settlement conferences prior to the start of the first trials in November 2022. These lawsuits have been consolidated before a federal judge in New Jersey where the national discovery and evidence-gathering process is underway.

Basis of claims

Clearly, the makers of Nexium, Prilosec and other Acid Reflux drugs failed to inform doctors and patients about the risk of kidney and renal failure, including acute interstitial nephritis (AIN), associated with their medication. Apparently, there was a lack of warning from the pharmaceutical companies regarding the connection between acid reflux drugs and kidney issues

Thus, users of the following proton pump inhibitors may be eligible for financial compensation: Nexium, Prilosec, Dexilant, Protonix, Prevacid, AcipHex, Vimovo, and Zegerid.


According to senior author Dr. Ziyad Al-Aly from the Washington University School of Medicine, those who use protein pump inhibitors (PPIs) had a 25% higher chance of dying as compared to patients using H2 blockers.

For every 500 patients who take PPIs for a year, one death that could be attributable to medication use occurs. Moreover, continued PPI use raises the risk of early death.

Acute kidney injury

Serious adverse effects from Nexium, Prilosec, and other acid reflux medications include acute kidney injury (AKI), renal failure, heart damage, bone fractures, and strokes. Use of these medications for more than a year increases the risk of hip, wrist, and spine fractures, especially in people over 50. In comparison to non-users, PPI users are thought to have a 20–50% higher risk of chronic renal disease and a 20–30% higher risk of stroke.

Stomach cancer

The manufacturers of Nexium, Prilosec, and other well-known acid reflux medications are being sued for neglecting to alert consumers and the medical community to the serious health concerns, including kidney damage and stomach cancer, connected with their use.

Further, PPIs, often known as acid reflux medications, have negative effects. Hence, lawyers are actively looking into product liability cases for people who have had these side effects. Acute kidney injury, acute interstitial nephritis, chronic kidney disease, and kidney or renal failure are among the injuries being assessed in these lawsuits.

1990s studies

Proton pump inhibitors (PPIs), a class-action medicine used to treat heartburn, have been the target of more than 15,000 lawsuits. While previously regarded as safe, these acid reducers have been associated with serious health issues include acute interstitial nephritis, kidney disease, and kidney failure.

Apparently, several scientific studies have linked long-term usage of proton pump inhibitors (PPIs) like Prilosec and Nexium with major health issues like pneumonia and bone fractures since the debut of PPIs in the 1990s.

2015 study

However, in 2015, solid proof that prolonged PPI usage can greatly increase the risk of irreversible kidney damage came to light. Because kidney damage may not be immediately apparent as a result of the medicine, researchers are concerned about the link between acid reflux medications and the illness.

Here, 300,000 people over the age of 66 who began taking a proton pump inhibitor for the treatment of acid reflux between April 2002 and November 2011 provided the study’s data. Consequently, the results demonstrated that older people taking Nexium, Prilosec, or another PPI were more likely than those not taking the medication to suffer from acute kidney injury. Moreover, there was a three times greater chance for users of these acid reflux medications to develop acute interstitial nephritis.

Thus, using Nexium, Prilosec, or other proton pump inhibitors was associated to an elevated risk of renal disease and kidney failure. Further, this applies even for people who did not have a history of acute kidney injury, according to another study that was released in February 2017 (AKI).

September 2022 

Thousands of lawsuits related to proton pump inhibitors (PPIs) have been filed across the country by individuals who claim that drugs like Nexium and Prilosec resulted in them experiencing permanent kidney damage, bone fractures, and interstitial nephritis. As of September 2022, there are over 13,000 pending lawsuits regarding kidney damage caused by Nexium and Prilosec that are part of a class action multi-district litigation (MDL).

Aside from the over 13,000 Nexium and Prilosec kidney damage lawsuits pending in a class action Multi-District Litigation (MDL), there are additional cases involving acid-reducing drugs filed in various state courts, numbering more than 4,000. 

2019 status

In 2019, a $2.15 billion settlement agreement was approved by a federal court between AstraZeneca and plaintiffs who claimed that Nexium caused kidney damage, setting a precedent for other settlements from drug manufacturers. Pfizer also reached a settlement of $2 billion in 2020 for the marketing of Protonix without proper warning about health risks. 

Consequently, the U.S. Department of Justice reached a settlement with Teva Pharmaceuticals in 2017. This was over accusations of paying kickbacks for prescriptions of Protonix and Kapidex/Dexilant. Currently, there is currently no nationwide settlement or class action lawsuit for Prilosec and Nexium.

Hence, individuals can still file lawsuits against the drug makers for resulting adverse health effects. 

As of yet, no agreements or announcements of settlements have been made. However, the PPI injury litigation process is still in its early stages.

An increasing number of product liability lawsuits are being filed against makers of proton pump inhibitors (PPIs).

Do I qualify for an acid reflux Lawsuit?

You may qualify to file Nexium, Prilosec and Acid Reflux Drug lawsuits if you meet all of the following criteria:

  • Less than 76 years old
  • Brand name or Brand generic OTC (No generic only)
  • 2020 or later diagnosis of one of the following: Acute Interstitial Nephritis (AIN); Acute Kidney Injury (AKI); Chronic Interstitial Nephritis (CIN); Chronic Kidney Disease (CKD) Stage 4 or 5, or End Stage Renal Disease (ESRD).
man recovering in hospital who's filed a Nexium, Prilosec and acid reflux drug lawsuit
weighing the benefits of Nexium, Prilosec and acid reflux drug lawsuit

What are my legal fees to file an acid reflux Lawsuit?

No upfront payment at all.

Basically, your legal representation will be an entirely contingent fee.

Hence, you pay nothing out of pocket. The legal costs and expenses come out of the settlement or award you receive. 

Further, on the unlikely possibility that the case is not settled or won, you will owe nothing. The representing law firm assumes the risk for you.

What is the average settlement amount for an acid reflux lawsuit?

Our leading acid reflux lawsuit lawyers estimate that  settlements may be worth anywhere from $25,000 to $200,000 per plaintiff.

Of course, this is an estimate since the ultimate amount depends on the severity of the injury.

So, contact us now to discuss further details.

celebrating a Nexium, Prilosec and acid reflux drug lawsuit settlement
lawyer counseling about Nexium, Prilosec and acid reflux drug lawsuit

Will I have any obligation to Lawsuit Help Desk if I qualify?

No. You have no obligations to us if you’re qualified.

Instead, our leading acid reflux lawsuit lawyers will discuss the retention agreement with you.

How long do I have to file my Lawsuit?

You should not delay.

Why? Statutes of limitations, worsened by lagging scientific research, may prevent your recovery.

Also, if you file late, you may miss important settlement opportunities.  That’s why it’s very important to secure legal representation as soon as possible.

In fact, one of our lawyers’ first actions for you will be to check your state’s statute of limitations and repose. 

This is because each state has its own statutes of limitations (SOL) and statutes of repose (SOR).

Basically, these statutes prevent lawsuits from being filed or enforced after preset time limits.

Hence, when the prescribed period for filing expires, any lawsuit you file thereafter will be dismissed.

It may have taken years for scientific research to show a connection between the cause – here, Nexium, Prilosec, or other acid reflux drug – and the injured person’s health conditions.

So, contact us now to get more details from our top acid reflux lawsuit lawyers.

Unfortunately, if you file your lawsuit late, you will miss settlement opportunities.

Basically, in order for you to qualify as a recovery victim, your lawyer must have already filed your lawsuit.

Therefore, act now. Talk to our experienced lawsuit lawyers.

lawyers sprinting to file a Nexium, Prilosec and acid reflux drug lawsuit
client contacts lawyer about Nexium, Prilosec and acid reflux drug lawsuit

What are my next steps for filing and settling my acid reflux lawsuit?

That’s simple! Call us for a quick assessment of your case. Do it today. Get peace of mind. 

Also, start saving every document our attorneys may need as evidence.

Our acid reflux lawsuit lawyers will tell you much more when you contact us. 

Lawsuit Help Desk: The Right Choice

We connect you directly to the best Prilosec lawsuit attorneys, without any intermediaries.

Unlike most others, we do not act like third-party middlemen. It is these leading Prilosec lawsuit  lawyers who decide whether your case has merit.

We will be forthright and honest with you.

Our mission is to connect you directly with experienced Prilosec lawsuit lawyers, with no middlemen involved.

Essentially, this is for public service.

Our purpose is to inform – not to market or solicit, and we won’t make robocalls.

We do not consider ourselves a marketing firm. We will only email you to provide helpful

With Lawsuit Help Desk, you can trust that your case is in good hands with our team of skilled lawyers.

In fact, Lawsuit Help Desk founder, Cameron Tousi, is a leader in the world of complex litigation. He has received the highest distinctions in peer reviews and awards from America’s leading legal publications.

If you’d like to speak with Cameron, call now! 

Monthly Status Updates: Nexium, Prilosec and Other Acid Reflux Lawsuits

There are settlement rumors.

Nevertheless, the nearly 13,000 PPI cases in the MDL class action lawsuit and numerous others in state court continue to be litigated.

Reider v. AstraZeneca

The first bellwether trial is scheduled to begin in October, featuring the case of James Reider v. AstraZeneca Pharmaceuticals LP and others. In preparation for the trial, the defense has recently filed several motions aimed at limiting or excluding testimony from certain witnesses for the plaintiff. 

Nexium class action

The judge in the Nexium class action lawsuit will hear these motions on September 19, just before the trial. The outcome of the Reider trial is expected to have a significant impact on the future of the PPI class action lawsuit, including settlement amounts. Additionally, two more bellwether trials are planned to take place next year.

PPI class action

Meanwhile, the PPI class action lawsuit is steadily progressing through discovery. The parties have been aggressively deposing witnesses and utilizing experts to discuss the science behind PPIs and their link to kidney damage. Additionally, AstraZeneca has agreed to turn over company documents that may shed light on how they marketed Nexium and other PPIs. This information could be critical in determining a favorable outcome for plaintiffs in this case. 

It’s important to note that these developments are not indicative of a settlement being reached any time soon; however, both sides continue to work towards an agreement that would resolve all claims against AstraZeneca without going to trial.

Basically, those involved in the Prilosec and Nexium class action lawsuits should continue to monitor the progress of this case and consult with their attorneys for guidance.  The next major update is expected in October, when the first bellwether trial begins.

Preemption doctrine

The defendants in the PPI drugs lawsuit argued that the plaintiffs’ lack of warning claims should be dismissed due to federal preemption. Basically, they said the FDA approved the warning labels for these drugs. Apparently, this argument could have ended the PPI lawsuits.

But Special Master Ellen Reisman suggested that the argument should be dismissed. She said the defendants cannot prove that the FDA would have rejected stronger warnings about kidney injuries. The first bellwether trial in the PPI MDL is set to begin in November.


In addition, the parties involved in the Pradaxa bleeding injury lawsuits agreed to a $650 million settlement. The settlement will be divided among plaintiffs who suffered serious or fatal bleeding after taking the blood thinner drug, Pradaxa.

Basically, the settlement includes payments for both current and past injuries. Claims must be submitted by March 2023 and cover economic losses like medical bills and non-economic damages such as pain and suffering.

Bayer AG

Finally, patients who took Xarelto are waiting for news of a settlement with Bayer AG and Johnson & Johnson’s Janssen Pharmaceutical Companies. The lawsuit claims that the companies failed to adequately warn users of the risks associated with taking the blood thinner.

However, recent reports suggest that negotiations between the drug makers and attorneys representing plaintiffs in the MDL have stalled due to a disagreement over the settlement amount. The parties plan to meet again in September 2022 for another round of negotiations.

Motion dismissed

Merck and AstraZeneca, the defendant pharmaceutical companies in the Proton Pump Inhibitor (Nexium/Prilosec) class action MDL, were unsuccessful in their attempt to dismiss the lawsuit. Apparently, the court denied their motion for summary judgment regarding the plaintiff’s failure to warn claim.

Basically, James Rieder’s Nexium kidney injury lawsuit centers on this issue. And the trial is set to proceed as scheduled in the fall.

MDL update

More than 500 similar lawsuits are part of the MDL. Generally, all of these are alleging failure to warn and other claims related to kidney injury, bone fractures, and other adverse health events caused by the long-term use of the proton pump inhibitors. Further, the plaintiffs assert that the drug makers should have warned them about these risks.

Merck settlement

The first trial is expected to set an important precedent regarding causation, liability, and damages. Moreover, the recent Merck settlement in California has given plaintiffs greater confidence in pursuing or considering legal action against pharmaceutical companies in relation to their PPI products.

In addition to the MDL, a class action lawsuit has been filed in California, accusing AstraZeneca of an illegal pricing scheme for Nexium that resulted in higher prices for consumers. This case is currently pending, and there are no updates at this time.

July 15, 2022

The Proton Pump Inhibitor (Prilosec/Nexium) Multi-District Litigation had 13,366 pending cases, which decreased from 13,437 cases the previous month. This decrease was due to plaintiffs voluntarily dismissing cases and only a few new cases being added. The first bellwether test trial will begin in November, just four months from now.

Further, the lawsuits accuse manufacturers of Prilosec, Nexium, and other proton pump inhibitors of failing to provide adequate warnings about the risks of kidney damage, bone fractures, and other serious side effects associated with the use of their products. The plaintiffs are seeking compensation for medical bills, pain and suffering, and other damages.

MDL Update

In addition to the 13,366 cases pending in MDL No. 2789, thousands of other claims are being pursued in state courts nationwide. It is expected that more plaintiffs will file lawsuits and join the MDL as information about side effects from Prilosec, Nexium, and other acid reflux medications continues to spread over time.

Both parties have engaged in pre-trial discovery, depositions, exchange of evidence, motions, and settlement negotiations.  Currently, the defendants have made several settlement offers, but plaintiffs’ lawyers have rejected them. Apparently, the latter are considering the proposed amount insufficient.

Thus, these rejections offer hope to those interested in pursuing a claim against AstraZeneca or any of the other PPI manufacturers.

Defense attorneys have attempted to dismiss the Prilosec and Nexium cases in the Proton Pump Inhibitor MDL, claiming federal preemption supersedes the ability of individuals to file lawsuits under state tort laws.

New Jersey decision

On May 23, 2022, a decision in the District of New Jersey, “In re Fosamax Alendronate Prod. Liab. Lit.,” might have an impact on this matter. The Special Master released CMO No. 75, which gave lawyers the opportunity to express their views on how the decision could impact a Prilosec or Nexium lawsuit.

However, the outcome of this case, which ruled in favor of the defendant, is believed to not affect the Nexium class action lawsuit.

Motion to Dismiss

The motion to dismiss the pending class action lawsuits is still under review. Further, the plaintiffs’ counsels are expected to file their opposition brief in June 2022.

Currently, all parties will wait for the court’s ruling on this matter before any further progress can be made on the Nexium-Prilosec lawsuit. Additionally, discovery proceedings in various state courts could impact how this case proceeds going forward.

No settlement negotiations are taking place. Clearly, the parties are waiting for the court’s decision on the motion to dismiss. However, if a settlement is reached between the parties, it will likely provide compensation for those who have been affected by Prilosec or Nexium use.

If a global settlement is not reached after the first set of bellwether trials in the Nexium-Prilosec Proton Pump Inhibitor class action Multi-District Litigation, the remaining 13,500 cases will be sent back for trial in large batches of several hundred. This will put significant pressure on both legal teams as they would need to prepare for a substantial number of PPI lawsuits.

MDL Update

In order to implement this plan, Judge Wolfson issued CMO #74, which outlines a group of 200 “Wave One” cases that the parties will begin preparing for trial in the coming months, followed by additional waves of several hundred cases each.

 The parties will also file a motion to extend the current discovery deadline and for additional time for expert disclosures. Judge Wolfson has encouraged the parties to settle their claims, but if no agreement is reached by April 2022, he intends to move forward with the Wave One trials. 

PPI Prilosec update

Clearly, the outcomes of these trials could have major implications for PPI users nationwide. It is important that those who are suffering from acid-related injuries due to Nexium or Prilosec remain informed and seek legal counsel if they believe they may be entitled to compensation. 

Currently, the experienced attorneys at the Consumer Justice Group are currently filing claims on behalf of victims seeking damages for medical bills, lost wages, and pain and suffering related to their PPI use. 

PAID ATTORNEY ADVERTISEMENT: This Website is a group advertisement. It is not a lawyer referral service. is owned and operated by Awon Holdings LLC and is not a law firm. We connect people to legal service and there is no charge to be connected with an attorney. You are under no obligation to retain any services of those connected through our website. We try our best to keep things fair and balanced to help you make the best choice for you. This information does not constitute legal or medical advice and it should not be relied upon as such. Results are not guaranteed and past performance is not an indication of future success. Always consult with your doctor before modifying your medication or regular medical regimen.

Copyright © 2023 - All Rights Reserved